Word

ENDO GENERICS PAR PHARMACEUTICAL

Status

Registered

Status Code

700

Status Date

Tuesday, May 16, 2023

Serial Number

97313223

Registration Number

7052815

Registration Date

Tuesday, May 16, 2023

Mark Type

3

Filing Date

Tuesday, March 15, 2022

Published for Opposition

Tuesday, February 28, 2023

Trademark Owner History

ENDO OPERATIONS LIMITED -
Endo Pharmaceuticals Inc. - Original Registrant

Classifications

41 Educational services, namely, conducting classes, seminars, and workshops in the field of pharmaceutical preparations and medicines, medical devices and techniques; Educational services, namely, conducting classes, seminars, workshops and training for doctors, nurses and others in the fields of critical care, critical testing, maternal health, rare diseases and conditions, anesthesia, and aesthetic solutions to help patients feel better about their bodies

40 Manufacture of pharmaceutical products to order and specification of others; Providing technical information in the field of pharmaceutical manufacturing

5 Pharmaceutical and medical preparations and ready-to-administer injectable pharmaceutical and medical preparations in connection with critical care, critical testing, maternal health, anesthesia, and for the treatment of pain, allergic reactions, hypotension, shock, malignant diseases, kidney disorders, cellulite, skin care, dermatological use, folds, scars, and body contouring and for rejuvenating the skin, and to provide and reverse muscle relaxation, all to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities and in doctor's offices; Pharmaceutical preparations, namely, analgesics and pain management preparations, preparations for the treatment of cancers, preparations for the treatment of urological diseases and disorders, preparations for the treatment of schizophrenia; pharmaceutical preparations for the treatment of asymmetries and defects in conditions of the human skin; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, hormone replacement therapy preparations; drug substances, namely, enzymes for medical purposes; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care; medicated gels and creams for dermatological use; nutritional and dietary supplements; vitamins and mineral supplements; food supplements

44 Providing medical information and online medical information on the subjects of pharmaceutical preparations and medicines, medical devices and techniques; Providing medical information and online medical and healthcare information to healthcare professionals and patients; Providing a website featuring medical information; Providing medication counseling information, namely, advice and data on the subjects of pharmaceutical preparations and medicine

10 Medical devices for use in treating pelvic disorders; Medical devices for use in treating pelvic organ prolapse; Medical devices for use in treating urinary incontinence; Medical devices for use in pain management and alleviation; Medical devices, namely, surgical equipment in the fields of urology and men's health; Medical devices, namely, intrauterine devices; Injection syringes; Injection device for pharmaceuticals and medicine

42 Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Medical research in the fields of chemicals and pharmaceuticals; Scientific research and testing services in the fields of chemicals and pharmaceuticals; Research and development of new products for others in the fields of chemicals and pharmaceuticals; Development of pharmaceutical products to specifications of others

The mark consists of a hexagon shape on an angle with intermittent solid vertical lines, with the words "ENDO GENERICS" in lower case font to the right and the words "PAR PHARMACEUTICAL" in title case font underneath.
Color is not claimed as a feature of the mark.
"GENERICS" AND "PHARMACEUTICAL"

Trademark Events

Mar 21, 2022

New Application Office Supplied Data Entered

Mar 18, 2022

New Application Entered

Mar 22, 2022

Notice Of Design Search Code E-Mailed

May 10, 2022

Assigned To Examiner

May 16, 2022

Non-Final Action Written

May 16, 2022

Non-Final Action E-Mailed

May 16, 2022

Notification Of Non-Final Action E-Mailed

Aug 2, 2022

Teas Response To Office Action Received

Aug 2, 2022

Correspondence Received In Law Office

Aug 2, 2022

Teas/Email Correspondence Entered

Aug 23, 2022

Suspension Letter Written

Aug 23, 2022

Letter Of Suspension E-Mailed

Aug 23, 2022

Notification Of Letter Of Suspension E-Mailed

Nov 18, 2022

Teas Response To Suspension Inquiry Received

Jan 19, 2023

Assigned To Lie

Jan 20, 2023

Correspondence Received In Law Office

Jan 20, 2023

Teas/Email Correspondence Entered

Jan 23, 2023

Approved For Pub - Principal Register

Feb 8, 2023

Notification Of Notice Of Publication E-Mailed

Feb 28, 2023

Published For Opposition

Feb 28, 2023

Official Gazette Publication Confirmation E-Mailed

May 16, 2023

Registered-Principal Register

May 16, 2023

Notice Of Registration Confirmation Emailed

May 1, 2024

Automatic Update Of Assignment Of Ownership